Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Submitted by
admin
on February 6, 2014 - 6:08pm
Source:
Yahoo/Reuters
News Tags:
Spectrum Pharmaceuticals
FDA
Beleodaq
T-cell lymphoma
Headline:
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Do Not Allow Advertisers to Use My Personal information
